|
|
DGAPAdhoc: BRAIN Biotech AG / Key words: Miscellaneous
BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAINMetagenomeCas BMC, BRAINEngineeredCas BEC
04Apr2022 / 10:31 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is s... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: AGM/EGM
BRAIN Biotech AG: Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG
09.03.2022 / 16:00
The issuer is solely responsible for the content of this announcement.
Resolutions of the Annual General Meeting for the Fiscal Year 20... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Quarter Results/Forecast
BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting
23.02.2022 / 07:30
The issuer is solely responsible for the content of this announcement.
Zwingenberg, Germany, February 23rd, 2022
BRAIN Biotech... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Alliance
BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animalfree milk protein
08.02.2022 / 08:15
The issuer is solely responsible for the content of this announcement.
BRAIN Biotech and Formo: Strategic partnership of E... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Key words: Takeover
BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business
01.02.2022 / 17:45
The issuer is solely responsible for the content of this announcement.
Zwingenberg, Germany, February 1st, 2022BRAIN Gr... Lire le communiqué |
|
| |
|
| |
|
|
DGAPAdhoc: BRAIN Biotech AG / Key words: Takeover
BRAIN Biotech AG: BRAIN Group expands its food enzyme business with the acquisition of a majority of Breatec B.V. and Comix
01Feb2022 / 17:36 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is solely responsi... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: BRAIN Biotech AG
/ Schlagworte: Jahresbericht/Jahresergebnis
BRAIN Biotech AG veröffentlicht Geschäftsbericht für das Finanzjahr 2020/21
17.01.2022 / 07:30
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.
Zwingenberg, 17. Januar 2022BRAIN Biote... Lire le communiqué |
|
| |
|
| |
